Below is a featured video from the January 2025 case conference, during which Marc Tischkowitz, MD, PhD from the University of Cambridge and ICARE Founder, Tuya Pal, MD, discussed cancer risks and management among ATM heterozygotes.
ICARE Featured Video January 2025
ATM Heterozygotes: Cancer Risks and Management
ICARE Featured Video January 2025
ATM Heterozygotes: Cancer Risks and Management
Permanent link to this article: https://inheritedcancer.net/video10925/